The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers.


Peptide hormones can influence the development and growth of many cancers which are not considered classical hormone-dependent tumors. Analogs of somatostatin, bombesin/gastrin-releasing peptide (GRP), luteinizing hormone-releasing hormone (LH-RH) and growth hormone-releasing hormone (GH-RH) can interfere with receptors on tumor cells or intracellular… (More)
DOI: 10.1515/HMBCI.2010.018


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics